Images show greater rates of emphysema in individuals who smoke marijuana than in those who smoke tobacco-only cigarettes or non-smokers.
People who smoke marijuana face increased rates of emphysema compared to individuals who choose tobacco-only cigarettes.
In a scientific e-poster that will be presented during the 2021 ARRS Virtual Annual Meeting, researchers from Ottawa Hospital in Canada show that smoking marijuana not only elevates the emphysema rate overall, but the increase is even greater when patients are age-matched. In addition, the team saw greater rates of paraseptal emphysema.
To make this determination, the team, led by first author Luke Murtha, M.D., a diagnostic radiologist at Ottawa Hospital examined imaging reports from the facilities PACS system. They concentrated on three groups, matching them for age and sex: marijuana smokers (56 patients), non-smokers/non-marijuana users (57 patients), and tobacco-only smokers (33 patients).
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
A review by two board-certified, fellowship-trained radiologists who were blinded to smoking or marijuana-use history, completed consensus reading of chest CTs for the study group.
Based on their analysis, they determined 75 percent of main-group marijuana smoking patients had greatly elevated rates of emphysema compared with 5 percent of main-group control patients. Rates were even higher among the age-matched subgroup where 93 percent of marijuana smokers and 66 percent of tobacco-only smokers experienced significant increases in emphysema.
The team also identified a much higher proportion of paraseptal emphysema – compared to other types – in marijuana smokers. Of those individuals, 53 percent demonstrated paraseptal emphysema, while only 24 percent of tobacco-only smokers and 7 percent of non-smokers experienced it.
In addition to these findings, Murtha said, marijuana use was also linked to other conditions.
“Marijuana smoking is also associated with airways disease, including bronchial wall thickening, bronchiectasis, and bronchiolar mucoid impaction, in comparison to both the control group and tobacco-only group,” he said.
These findings can be significant, the team said, because legalization of and use of marijuana is changing.
“Given that marijuana use is increasing, particularly within nations, such as Canada, that have legalized the substance, it is important for us, as radiologists, to define specific findings associated with its consumption,” the team concluded.
Computed Tomography Insights on GI Bleeding: Nine Takeaways from New Consensus Recommendations
March 7th 2024In joint consensus recommendations issued from the Society of Abdominal Radiology and the American College of Gastroenterology, researchers discussed key pearls, benefits, and limitations of CT angiography for imaging of overt lower GI bleeding and CT enterography for detecting small bowel bleeding.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Deep Learning Bolster Image Quality with Low-Dose Lung CT?
March 4th 2024In comparison to standard-dose lung CT, the combination of deep learning image reconstruction with ultra-low-dose CT offered similar detection and characterization of pulmonary nodules at a nearly 93 percent reduction of radiation dosing, according to new research.
AMA Issues New CPT Code for AI Estimates of CCTA-Based Fractional Flow Reserve
February 26th 2024Clinicians can bill Category 1 CPT Code 75580 for adjunctive use of the artificial intelligence (AI)-powered Cleerly Ischemia software for fractional flow reserve estimates based on coronary computed tomography angiography (CCTA) scans.